ホーム › 白血病 › ニューヨーク › New York City
New York City、NYにおける白血病の臨床試験
New York Cityとその周辺地域（約30マイル以内）の拠点で、白血病に関する19件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
被験者募集中第1/2相
- Montefiore Medical Center, New York
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
被験者募集中第2相
- Weill Cornell, New York
A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes
被験者募集中第2相
- Memorial Sloan Kettering Cancer Center, New York
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
被験者募集中第2相
- Columbia University Medical Center New York Presbyterian, New York
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
被験者募集中第1相
- Memorial Sloan Kettering Cancer Center, New York
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
被験者募集中第3相
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University, New York
- Weill Cornell Medical Center, New York
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
被験者募集中第1相
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical College-NY Presbyterian Hospital, New York
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
被験者募集中第1/2相
- Research Site, New York
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
被験者募集中第2相
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
CD4CAR for CD4+ Leukemia and Lymphoma
被験者募集中第1相
- Albert Einstein Health Network, New York
A Study of Revumenib and Mezigdomide in People With Leukemia
被験者募集中第1/2相
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
被験者募集中第1/2相
- Dren Investigational Site 1, New York
- Dren Investigational Site 2, New York
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
被験者募集中健康なボランティア歓迎
- Memorial Sloan Kettering Cancer Center (All protocol activities), New York
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
被験者募集中第2相
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
被験者募集中第2/3相
- Perlmutter Cancer Center - 34th Street, New York
- Icahn School of Medicine at Mount Sinai, New York
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
被験者募集中第1相
- New York - Presbyterian / Weill Cornell Medicine, New York
- Mount Sinai - Ruttenberg Treatment Center, New York
- Columbia University Medical Center, New York
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
被験者募集中観察研究健康なボランティア歓迎
- Memorial Sloan Kettering Cancer Center, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, New York
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
被験者募集中第1相
- Memorial Sloan Kettering Cancer Center, New York
他の都市における白血病の試験
- Houston, TX28件の研究
- Boston, MA25件の研究
- Los Angeles, CA16件の研究
- Chicago, IL16件の研究
- Durham, NC13件の研究
- Philadelphia, PA12件の研究
- Nashville, TN12件の研究
- Columbus, OH12件の研究
- Baldwin Park, CA12件の研究
- Milwaukee, WI11件の研究
- Seattle, WA11件の研究
- Atlanta, GA11件の研究
New York Cityにおける他の研究
- 乳がん136件の研究
- 非小細胞肺癌121件の研究
- がん（全種類）109件の研究
- 前立腺がん103件の研究
- 転移性癌93件の研究
- 大腸癌78件の研究
- 卵巣がん69件の研究
- 肺がん60件の研究
- 多発性骨髄腫60件の研究
- 膵臓がん60件の研究
- 子宮内膜がん52件の研究
- 急性骨髄性白血病51件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。